Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. | Chief Legal Officer | Common Stock | 56K | $2.42M | $43.26 | Mar 1, 2024 | Direct |
Kymera Therapeutics, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 131K | Mar 1, 2024 | Direct | ||
Compass Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 40K | Feb 9, 2024 | Direct | ||
ALEXION PHARMACEUTICALS, INC. | EVP & Chief Legal Officer | Common Stock, par value $.0001 per share | 0 | $177.00 | Jul 21, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KYMR | Kymera Therapeutics, Inc. | Mar 1, 2024 | 2 | $0 | 4 | Mar 4, 2024 | Chief Legal Officer |
CMPX | Compass Therapeutics, Inc. | Feb 9, 2024 | 1 | $0 | 4 | Feb 14, 2024 | Director |
KYMR | Kymera Therapeutics, Inc. | Jan 4, 2024 | 1 | -$74.4K | 4 | Jan 5, 2024 | Chief Legal Officer |
CMPX | Compass Therapeutics, Inc. | Feb 8, 2023 | 1 | $0 | 4 | Feb 9, 2023 | Director |
KYMR | Kymera Therapeutics, Inc. | Jan 3, 2023 | 2 | $0 | 4 | Jan 4, 2023 | Chief Legal Officer |
KYMR | Kymera Therapeutics, Inc. | Jan 3, 2023 | 0 | $0 | 3 | Jan 4, 2023 | Chief Legal Officer |
CMPX | Compass Therapeutics, Inc. | Apr 26, 2022 | 1 | $0 | 4 | Apr 28, 2022 | Director |
CMPX | Compass Therapeutics, Inc. | Apr 26, 2022 | 0 | $0 | 3 | Apr 28, 2022 | Director |
ALXN | ALEXION PHARMACEUTICALS, INC. | Jul 21, 2021 | 1 | $0 | 4 | Jul 23, 2021 | EVP & Chief Legal Officer |
ALXN | ALEXION PHARMACEUTICALS, INC. | Jul 14, 2021 | 2 | $0 | 4 | Jul 16, 2021 | EVP & Chief Legal Officer |